148 related articles for article (PubMed ID: 12632183)
1. The role of endogenous angiotensin II in ischaemia, reperfusion and preconditioning of the isolated rat heart.
Xiao XH; Allen DG
Pflugers Arch; 2003 Mar; 445(6):643-50. PubMed ID: 12632183
[TBL] [Abstract][Full Text] [Related]
2. Activity of the Na(+)/H(+) exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart.
Xiao XH; Allen DG
Cardiovasc Res; 2000 Nov; 48(2):244-53. PubMed ID: 11054471
[TBL] [Abstract][Full Text] [Related]
3. Effects of the angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion.
Flynn JD; Akers WS
Pharmacotherapy; 2003 Nov; 23(11):1401-10. PubMed ID: 14620386
[TBL] [Abstract][Full Text] [Related]
4. Role of Na(+)/H(+) exchanger during ischemia and preconditioning in the isolated rat heart.
Xiao XH; Allen DG
Circ Res; 1999 Oct; 85(8):723-30. PubMed ID: 10521246
[TBL] [Abstract][Full Text] [Related]
5. Influence of ischemic preconditioning on intracellular sodium, pH, and cellular energy status in isolated perfused heart.
Babsky A; Hekmatyar S; Wehrli S; Doliba N; Osbakken M; Bansal N
Exp Biol Med (Maywood); 2002 Jul; 227(7):520-8. PubMed ID: 12094017
[TBL] [Abstract][Full Text] [Related]
6. Ischemic preconditioning stimulates sodium and proton transport in isolated rat hearts.
Ramasamy R; Liu H; Anderson S; Lundmark J; Schaefer S
J Clin Invest; 1995 Sep; 96(3):1464-72. PubMed ID: 7657818
[TBL] [Abstract][Full Text] [Related]
7. AICAR inhibits the Na+/H+ exchanger in rat hearts--possible contribution to cardioprotection.
Moopanar TR; Xiao XH; Jiang L; Chen ZP; Kemp BE; Allen DG
Pflugers Arch; 2006 Nov; 453(2):147-56. PubMed ID: 16983558
[TBL] [Abstract][Full Text] [Related]
8. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.
Yang BC; Phillips MI; Zhang YC; Kimura B; Shen LP; Mehta P; Mehta JL
Circ Res; 1998 Sep; 83(5):552-9. PubMed ID: 9734478
[TBL] [Abstract][Full Text] [Related]
9. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms.
Sato M; Engelman RM; Otani H; Maulik N; Rousou JA; Flack JE; Deaton DW; Das DK
Circulation; 2000 Nov; 102(19 Suppl 3):III346-51. PubMed ID: 11082412
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
11. Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age.
Webster I; Salie R; Marais E; Fan WJ; Maarman G; Huisamen B; Lochner A
BMC Physiol; 2017 Mar; 17(1):3. PubMed ID: 28302152
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cardiac preconditioning in the isolated heart of the transgenic ((mREN-2) 27) hypertensive rat.
Randall MD; Gardiner SM; Bennett T
Cardiovasc Res; 1997 Feb; 33(2):400-9. PubMed ID: 9074705
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
Zhu P; Zaugg CE; Hornstein PS; Allegrini PR; Buser PT
J Cardiovasc Pharmacol; 1999 May; 33(5):785-90. PubMed ID: 10226867
[TBL] [Abstract][Full Text] [Related]
14. Use of losartan to examine the role of the cardiac renin-angiotensin system in myocardial dysfunction during ischemia and reperfusion.
Werrmann JG; Cohen SM
J Cardiovasc Pharmacol; 1996 Feb; 27(2):177-82. PubMed ID: 8720414
[TBL] [Abstract][Full Text] [Related]
15. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological concentration of angiotensin-(1-7) activates NADPH oxidase after ischemia-reperfusion in rat heart through AT1 receptor stimulation.
Oudot A; Vergely C; Ecarnot-Laubriet A; Rochette L
Regul Pept; 2005 Apr; 127(1-3):101-10. PubMed ID: 15680476
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion.
Oudot A; Vergely C; Ecarnot-Laubriet A; Rochette L
Eur J Pharmacol; 2003 Feb; 462(1-3):145-54. PubMed ID: 12591107
[TBL] [Abstract][Full Text] [Related]
19. Losartan improves recovery of contraction and inhibits transient inward current in a cellular model of cardiac ischemia and reperfusion.
Louch WE; Ferrier GR; Howlett SE
J Pharmacol Exp Ther; 2000 Nov; 295(2):697-704. PubMed ID: 11046108
[TBL] [Abstract][Full Text] [Related]
20. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
